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Abstract The mechanism responsible for the ability of bradyki- 
nin to cause calcium-dependent release of glutamate from astro- 
cytes in vitro was investigated. The glutamate transport inhibitor, 
dihydrokainate, did not block bradykinin-induced glutamate re- 
lease, and bradykinin did not cause cell swelling. These data 
exclude the involvement of glutamate transporters or swelling 
mechansims as mediating glutamate release in response to 
bradykinin, a-Latrotoxin (3 nM), a component of black widow 
spider venom, stimulated calcium-independent glutamate release 
from astrocytes. Since c~-latrotoxin induces vesicle fusion and 
calcium-independent euronal neurotransmitter release, our data 
suggest that astrocytes may release neurotransmitter using a 
mechanism similar to the neuronal secretory process. 
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1. Introduction 
Astroglia are now thought o play many roles in the nervous 
system. While initially they were thought to be a 'nerve glue' 
[1], it is clear that they also have the potential to play dynamic 
roles. Neurons have been shown to signal to adjacent glia [2-4]. 
Waves of calcium can propagate amongst electrically coupled 
glia [2,5-9], and glia can signal back to adjacent neurons [10,11]. 
Stimuli that specifically elevate astrocyte calcium levels cause 
a subsequent elevation of neuronal calcium [10-12]. Glia-neu- 
ron signaling may be mediated by multiple signaling mecha- 
nisms including gap junctions [11] and the release of neuro- 
transmitters [10]. 
Our previous work has demonstrated that bradykinin ele- 
vates internal calcium levels of cortical astrocytes [10] which 
evokes the calcium-dependent release of the excitatory amino 
acids (EAAs) glutamate and aspartate. When astrocytes are 
co-cultured with neurons, bradykinin stimulates the release of 
glutamate from astrocytes which causes an elevation of neu- 
ronal calcium that is mediated by the N-methyl-D-aspartate 
(NMDA)  receptor [10]. The nature of the astrocyte glutamate 
release mechanism responsible for mediating astrocyte-neuron 
signaling has not been defined. 
There are three prominent mechanisms that could mediate 
the release of neurotransmitter from astrocytes: (i) the reverse 
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operation of a glutamate transporter [13], (ii) release through 
a swelling-induced pathway [14], or (iii) a calcium-dependent 
vesicle release mechanism [15]. In this study we have investi- 
gated the mechanism responsible for controlling release of neu- 
rotransmitter f om astrocytes. 
2. Materials and methods 
2.1. Cell culture 
Enriched astrocyte type-1 cultures were prepared from 1- to 4-day- 
old Sprague-Dawely rat cortices as previously described [10,16]. 
Briefly, cortices were freshly dissected and tissue was enzymatically 
(papain 20 IU/ml; 1 h at 37°C) and mechanically dissociated. The cells 
were plated into culture flasks and maintained at 37°C in a humidified 
5% COJ95% air atmosphere. After 7-13 days in culture, cells were 
shaken twice, first for 1.5 h and then for 18 h on an orbital shaker at 
260 rpm. The population of adherent cells was subsequently detached 
using trypsin (0.1%). Detached cells were spun at 100 x g for 10 min, 
resuspended and plated either onto poly-L-lysine (1 mg/ml; MW 
100,000)-coated glass coverslips (for release studies) inlayed in a 35 mm 
culture dish or into glass-bottomed dishes (for imaging experiments). 
Enriched cultures were kept at 37°C in a humidified 5% COJ95% air 
atmosphere. All experiments were performed on cells that have been 
in culture for 3-5 days after re-plating. 
2.2. Immunocytochem&try 
Immunocytochemistry was performed using antibodies raised 
against glial fibrillary acidic protein (GFAP; 1 : 5000, ICN Immunobi- 
ological) and the microtubule associated protein, MAP-2 (1:2000; 
Boehringer). Antibody visualization was accomplished by using a Vec- 
tastain ABC kit (Vector) with nickel-intensification. 
2.3. Excitatory amino acid release 
Coverslips containing astrocyte cultures were mounted into a 50/11 
perfusion chamber. Saline was perfused at a rate of 200,ul/min and was 
collected to determine the levels of excitatory amino acids in 1 min 200 
/tl samples. Excitatory amino acid levels were determined by high- 
performance liquid chromatography (HPLC) with fluorescence detec- 
tion as previously described [10]. Saline used for perfusion contained 
(in mM): NaC1 140, KC1 5, MgC12 2, CaC12 , and HEPES 10 (pH 7.4). 
In calcium-depleted Solution, calcium was replaced by 1 mM EGTA, 
3.8 mM MgCI2 and 0.2 mM CaC12 to yield 26 nM free calcium. Max 
Chelator (version 5.6), written by Chris Patton at Stanford University, 
was used to estimate free extracellular calcium levels. All amino acid 
release xperiments were performed at 37°C. 
2.4. Volume measurement 
Cells were incubated with BCECF-AM (5/,tM) and 0.02% pluronic 
acid for 40 min at 37°C. After several washes cells were kept at 37°C 
for 40 min to permit dye de-esterification. All experiments were per- 
formed at room temperature (22-24°C). The content of normal imaging 
solution was identical to that of saline used for HPLC experiments. The 
osmolarity of this solution was 286-302 mOsm/kg as determined using 
a freezing point osmometer (Advanced Instruments Inc). In hyposmotic 
solution NaC1 was reduced to 90 mM (measured osmolarity 202-203 
mOsm/kg). BCECF was excited at 440 nm and emission was collected 
at 510 nm using a SIT camera, a Matrox frame grabbing board and 
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Image-1 software (Universal Imaging). Hyposmotic solution and 
bradykinin (1 pM) were bath applied for 100 s. Images of astrocytes 
were acquired and the intensity of dye emission was quantified. Previ- 
ous studies have shown thatwhen cells swell the dye trapped in cells 
is diluted leading to a reduction i  fluorescence emission intensity [17]. 
We find that BCECF effectively monitors the immediate swelling re- 
sponse of astrocytes to hyposmotic media as well as the subsequent 
regulatory volume decrease that has been characterized by other meth- 
ods [18]. 
2.5. Calcium imaging 
Cells were incubated with Fura-2AM (2 pM) and 0.02% pluronic acid 
for 40 min at 37°C. After several washes cells were k ptat 37°C for 
40 min to permit dye de-esterification. All imaging experiments were 
performed at room temperature (22 24°C) according to previously 
described methodology [10,19]. The contents of normal and calcium- 
depleted solutions were identical to those of salines used for HPLC 
experiments. Latrotoxin (3 nM; Alomone labs) was bath applied, while 
bradykinin (1 pM) was applied by pressure ejection (1 rain). 
3. Results and discussion 
Phase-contrast microscopy indicated that these cultures were 
devoid of neurons. This was confirmed by immunocytochemis- 
try which demonstrated that cultures lacked MAP2 im- 
munoreactivity but were immunopositive for glial fibrillary 
acidic protein (GFAP; Fig. la,b). In parallel cultures which 
contained neurons, MAP2 immunoreactivity was reliably de- 
tected (Fig. lc). Therefore, cultures in the current study are 
neuron-free and contain GFAP-positive polygonal astrocytes. 
We have previously shown that bradykinin-induced release 
of neurotransmitter from astrocytes i  not blocked by the gluta- 
mate transport inhibitors p-chloromercuriphenylsulphonic acid 
(p-CMPS) and L-trans-pyrrolidine-2,4-dicarboxylate (PDC) 
[10]. To further test the potential involvement of glutamate 
transporters in mediating bradykinin-induced glutamate re- 
lease we have used ihydrokainate (DHK) which blocks both 
glutamate uptake and the reverse operation of glutamate trans- 
porters [20]. 
The release of glutamate was monitored from astrocyte cul- 
tures by collecting superfusate hat was subjected to HPLC [10]. 
Under resting conditions there was a basal release of glutamate 
from astrocytes into the saline (Fig. 2a). Bradykinin caused a 
dose-dependent stimulation of glutamate release (Fig. 2a) as 
detected by the elevated levels of glutamate in the superfusate. 
Ten nM bradyknin elevated glutamate l vels from 43 + 7 nM 
to 87 + 13 nM (mean + S.E.M., n = 6), while 100 nM elevated 
glutamate l vels from 51 + 12 nM to 140 + 18 nM (n = 6). Ad- 
dition of DHK elevated the basal evel of glutamate, indicating 
that DHK effectively reduced the activity of the glutamate 
transporter (Fig. 2b). Bradykinin stimulated the release of glu- 
tamate in the presence of DHK. Therefore, we conclude that 
bradykinin activates glutamate release from astrocytes through 
a mechanism distinct from the glutamate transporter since 
DHK does not reduce bradykinin-induced glutamate release. 
Kimelberg and colleagues [14,18] have demonstrated that 
hyposmotic media cause a cell swelling-dependent, calcium- 
independent release of EAAs from astrocytes. To ask whether 
bradykinin might utilize such a mechanism we monitored astro- 
cyte volume using BCECF. At an excitation wavelength of 440 
nm BCECF is pH-insensitive. Cell swelling results in a dilution 
of the dye that leads to a reduction in the fluorescence intensity 
[17]. Treatment with hyposmotic medium reversibly reduced 
the BCECF fluorescence signal demonstrating that it is an 
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Fig. 1. (A) Astrocyte cultures are immunopositive with anti-GFAR 
(B) Astrocyte cultures are devoid of immunoreactivity for MAP2, de- 
monstrating that the cultures are neuron-free. (C) Co-cultures of neu- 
rons and astrocytes were treated with anti-MAP2. Immunopositive 
neurons act as a positive control for B. 
effective method monitoring cell volume (Fig. 2c) [17]. Addition 
of bradykinin, however, did not significantly modify the inten- 
sity of the fluorescence signal (Fig. 2c). Since bradykinin does 
not change cell volume it must utilize a release mechanism 
distinct from the cell swelling pathway to stimulate the release 
of glutamate from astrocytes. 
An active component of black widow spider venom, a-latro- 
toxin, binds to a receptor on nerve terminals which induces the 
release of neurotransmitter by directly stimulating the secretory 
machinery [21]. At least one of the receptors i  a member of a 
distinct protein family, the neurexins, which are transmem- 
brane proteins that bind intracellularly to the neuronal synaptic 
vesicle protein, synaptotagmin [22]. By directly interacting with 
synaptic proteins a-latrotoxin bypasses the calcium-require- 
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ment of transmitter release. To ask whether the astrocyte re- 
lease machinery has fundamentally similar properties to the 
vesicular apparatus of the nerve terminal we tested the action 
of ~-latrotoxin on glutamate release from purified astrocytes. 
Addition of 3 nM ~-latrotoxin rapidly increased the level of 
glutamate in the superfusate (Fig. 3a). c~-Latrotoxin signifi- 
cantly increased the concentration f glutamate in the super- 
fusate from 7+2 nM to 18+3 nM (n=6 ; paired t-test 
P < 0.02; Fig. 3a). Previous studies have shown that ~-latro- 
toxin has two actions, it forms channels in the plasma mem- 
brane that cause a calcium elevation, and it can directly stimu- 
late secretory machinery through interactions with c~-latrotoxin 
receptors [23-26]. We asked whether c~-latrotoxin directly stim- 
ulates the astrocyte glutamate r lease mechanism by removing 
external calcium ions. Application of c~-latrotoxin  calcium- 
depleted saline (estimated free calcium 26 nM) stimulated gluta- 
mate release to a similar magnitude as that induced when exter- 
nal calcium ions were present (Fig. 3a). However, in calcium- 
depleted saline ~-latrotoxin only transiently stimulated 
glutamate release. Following this initial period of induced 
release, the levels of glutamate declined until this amino acid 
was undetectable in the saline. In neurons a similar decline in 
transmitter release has been shown when c~-latrotoxin s applied 
in calcium-depleted saline. Parallel electron microscopy has 
indicated that this is due to a depletion of the vesicles in the 
nerve terminal [25,26]. Similar effects of ~-latrotoxin i  neurons 
and astrocytes raises the possibility that the transmitter release 
mechanisms of these two cell types share some fundamental 
properties. 
To further investigate the calcium-dependence of c~-latro- 
toxin action on astrocytes we monitored intracellular free cal- 
cium levels. Astrocytes were loaded with the calcium-sensitive 
indicator Fura-2. Bradykinin (1/tM), which stimulates gluta- 
mate release through receptor-mediated calcium elevation, 
raised the internal calcium level of astrocytes from 83 + 8 to 
444 + 52 nM (mean + S.E.M.; n = 26; Fig. 2d,e). By contrast, 
~-latrotoxin (3 nM) which significantly stimulated glutamate 
release, only elevated internal calcium from 69 + 4 to 87 + 5 
nM (P < 0.01, paired t-test; n = 34; Fig. 3b-d) when calcium 
ions were present in external saline. In calcium-depleted saline, 
~-latrotoxin (3 nM) did not significantly elevate internal cal- 
cium levels (P > 0.33, paired t-test; n = 29; Fig. 3b). 
When taken together with the HPLC glutamate r lease data 
shown in Fig. 3a, these calcium imaging experiments demon- 
strate that c~-latrotoxin exerts effects on astrocytes that are 
similar to the toxin's actions on neurons, c~-latrotoxin stimu- 
lates an increase in basal release from neurons in the presence 
and absence of external calcium ions [25,26]. In the absence of 
external calcium ions transmitter release is stimulated through 
a direct induction of exocytosis. Similar to these neuronal data, 
c~-latrotoxin stimulated glutamate r lease from astrocytes inthe 
absence xternal calcium (Fig. 3a) and without a detectable 
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Fig. 2. (A) Bradykinin (n = 8 at 10 nM, n = 4 at 100 nM) causes adose-dependent release of glutamate from astrocytes a  measured by HPLC [10] 
of superfusate. (B)The glutamate ransport inhibitor DHK (50/tM) elevates the basal level of glutamate inthe superfusate, indicating that it effectively 
blocks transporter activity, but does not block bradykinin i duced glutamate r lease. (C) Astrocytes were loaded with BCECF to monitor cell volume. 
Dye was excited at 440 nm and emission was collected at 510 nm. Addition of hyposmotic medium (hypo 1) caused cell swelling, detected as a reduction 
in intensity of the fluorescence signal (P < 0.01). Changes in cell volume are represented asthe change in fluorescence intensity/original intensity 
(AF/Fo). Addition of bradykinin (1/zM) did not change the fluorescence intensity (P > 0.25). Subsequent addition of hyposmotic medium (hypo 2) 
significantly reduced fluorescence intensity (P < 0.01). Thus, bradykinin does not cause cell swelling. (D) Bradykinin (1/~M) elevates calcium levels 
in astrocytes. 
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Fig. 3. (A) ~-Latrotoxin (3nM) stimulates the release of glutamate from astrocytes. In the presence ofexternal calcium, c~-latrotoxin causes a sustained 
release of glutamate. However, in calcium-depleted saline, ~-latrotoxin causes a transient s imulation ofglutamate r lease. Subsequently, all glutamate 
release is inhibited. (B) Summary data demonstrating the effect of cc-latrotoxin o  internal calcium levels of astrocytes. In the presence ofexternal 
calcium, c~-latrotoxin, causes a small elevation of internal calcium level (n = 34). In calcium-depleted saline ~-latrotoxin does not elevate internal 
calcium levels (n = 29). (C and D) When viewed on a cell by cell basis in the presence ofexternal calcium, ~-latrotoxin, can cause transient elevations 
of calcium (C) as well as a gradual increase in internal calcium level (D). 
calcium elevation (Fig. 3b). These data are consistent with 
~-latrotoxin directly stimulating transmitter release from astro- 
cytes. 
Previous studies in neurons and our studies in astrocytes 
(Fig. 2a and 3a) demonstrate hat there is an external calcium- 
dependence for sustained transmitter release in response to 
c~-latrotoxin. In neurons the requirement for external calcium 
has been identified. Correlated electron microscopy and elec- 
trophysiology has demonstrated that in the absence of external 
calcium, ~-latrotoxin stimulates transmitter release and a loss 
of synaptic vesicles [25,26]. ~-Latrotoxin stimulates transmitter 
release transiently because xternal calcium is needed for endo- 
cytosis and the replenishment of the pool of transmitter filled 
vesicles. Since astrocytes have a similar calcium-dependence for 
sustained transmitter release this data provides the first indica- 
tion that astrocytes have a transmitter release mechanism sim- 
ilar to that of neurons. However, the identification of the exact 
nature of this secretory process and whether it represents a 
vestigial expression of the neuronal vesicular elease mecha- 
nism requires further structural and biochemical study. 
Three potential glutamate release mechanisms have been 
suggested as having the potential to mediate bradykinin- 
induced glutamate release [10,27]. Our data using PDC, 
pCMPS and DHK demonstrate hat a glutamate transporter 
does not mediate bradykinin-induced glutamate release. In 
addition our data do not support a swelling-induced release 
mechanism. We have previously shown that the anion transport 
inhibitor, furosemide, blocks bradykinin-induced glutamate r - 
lease [10]. This suggested that a furosemide-sensitive sw lling- 
induced mechanism [14] might mediate glutamate r lease. How- 
ever, the astrocyte swelling release mechanism is not calcium- 
sensitive [14,18]. In this study we have investigated the relation- 
ship between swelling and bradykinin-induced glutamate re- 
lease further. Since we demonstrate hat bradykinin does not 
cause cell swelling, but does cause glutamate release, we con- 
clude that a mechanism distinct from the swelling-induced re-
lease mechanism ust mediate glutamate release. The ability 
of ~-latrotoxin to stimulate transmitter release from astrocytes 
suggests hat they may contain atransmitter release mechanism 
similar to that of neurons. This raises the hypothesis that 
bradykinin causes glutamate release using such a secretory 
process. 
It is perhaps not surprising that astrocytes contain a secre- 
tory system that has similarities to the neuronal release process 
given that muscle and fibroblasts are capable of quantal trans- 
mitter elease under appropriate conditions [28,29]. Because of 
limitations with our HPLC assay for transmitter release it has 
not been possible to compare the kinetics of transmitter release 
from neurons and astrocytes nor to determine whether astro- 
cyte release is quantal. However, the conservation of proteins 
regulating membrane traffic from yeast to man [30] suggests 
that similar building blocks will be used for calcium-regulated 
transmitter release in neurons and astrocytes of the same spe- 
cies. The particular molecular details and structural organiza- 
tion of this astrocyte release machinery remain to be identified. 
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